{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:58:06Z","timestamp":1793656686670,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jjcc.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:35:51Z","timestamp":1758584151000},"page":"592-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Daprodustat for patients with heart failure and renal anemia: A pilot multicenter, open-label, randomized controlled study"],"prefix":"10.1016","volume":"86","author":[{"given":"Yu Suresvar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shitara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Miyakuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Hiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikuo","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.09.011_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchf.2017.08.023","article-title":"Anemia in heart failure: still relevant?","volume":"6","author":"Grote Beverborg","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0010","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1253\/circj.CJ-15-0174","article-title":"Prognostic impact of anemia in patients with chronic heart failure- with special reference to clinical background: report from the CHART-2 study","volume":"79","author":"Yamauchi","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0015","first-page":"568","article-title":"Association between anemia, clinical features and outcome in patients hospitalized for acute heart failure syndromes","volume":"4","author":"Kajimoto","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0025","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0735-1097(01)01470-X","article-title":"Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction","volume":"38","author":"Al-Ahmad","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0035","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0040","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0045","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jjcc.2023.06.012","article-title":"Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials","volume":"83","author":"Bhatia","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0055","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.kisu.2017.09.002","article-title":"New options for the anemia of chronic kidney disease","volume":"7","author":"Coyne","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jjcc.2022.09.002","article-title":"The roles of HIF-1\u03b1 signaling in cardiovascular diseases","volume":"81","author":"Sato","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ijms19020389","article-title":"Hypoxia-inducible factor and its role in the management of anemia in chronic kidney disease","volume":"19","author":"Kaplan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0075","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.kint.2017.02.035","article-title":"Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease","volume":"92","author":"Sugahara","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0080","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1681\/ASN.2015030241","article-title":"Roxadustat (FG-4592): correction of anemia in incident dialysis patients","volume":"27","author":"Besarab","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.freeradbiomed.2018.06.025","article-title":"Misdistribution of iron and oxidative stress in chronic kidney disease","volume":"133","author":"Nakanishi","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0090","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cardfail.2014.01.008","article-title":"Inappropriate expression of hepcidin by liver congestion contributes to anemia and relative iron deficiency","volume":"20","author":"Suzuki","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2019.00093","article-title":"Thin air, thick vessels: historical and current perspectives on hypoxic pulmonary hypertension","volume":"6","author":"Young","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-017-1543-3","article-title":"Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+\/CD11b+ subpopulations and cardiac repair","volume":"95","author":"Ghadge","year":"2017","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0115","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/ehf2.14109","article-title":"Daprodustat for anaemia in patients with heart failure and chronic kidney disease: a randomized controlled study","volume":"9","author":"Iso","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000513103","article-title":"Daprodustat compared with epoetin beta pegol for anemia in Japanese patients not on dialysis: a 52-week randomized open-label phase 3 trial","volume":"52","author":"Nangaku","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0125","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2021.06.041","article-title":"Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure","volume":"338","author":"Ishiwata","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.0000000000000321","article-title":"Daprodustat and heart failure in CKD","volume":"35","author":"Cunningham","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jjcc.2023.10.009","article-title":"Heart failure management guidelines: new recommendations and implementation","volume":"83","author":"Heidenreich","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010125","article-title":"Iron deficiency in heart failure: mechanisms and pathophysiology","volume":"11","author":"Alnuwaysir","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1159\/000518071","article-title":"Efficacy and safety of molidustat for anemia in ESA-naive nondialysis patients: a randomized, phase 3 trial","volume":"52","author":"Yamamoto","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0160","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1681\/ASN.2020091311","article-title":"Phase 3 randomized study comparing vadadustat with darbepoetin alfa for anemia in Japanese patients with nondialysis-dependent CKD","volume":"32","author":"Nangaku","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2215\/CJN.15360920","article-title":"Heart failure hospitalization risk associated with iron status in veterans with CKD","volume":"16","author":"Cho","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011728","article-title":"Transferrin saturation, serum iron, and ferritin in heart failure: prognostic significance and proteomic associations","volume":"18","author":"Gan","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0175","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00419.2019","article-title":"Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease","volume":"318","author":"Uchida","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0180","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2337\/db21-0398","article-title":"Activation of HIF1\u03b1 rescues the hypoxic response and reverses metabolic dysfunction in the diabetic heart","volume":"70","author":"Sousa Fialho","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0185","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1602978113","article-title":"HIF2\u03b1-arginase axis is essential for the development of pulmonary hypertension","volume":"113","author":"Cowburn","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0190","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2005.08.045","article-title":"Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse","volume":"46","author":"Kido","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.109.922427","article-title":"Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy","volume":"122","author":"Moslehi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0200","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/jcbfm.2012.28","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?","volume":"32","author":"Karuppagounder","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0210","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.16011219","article-title":"Efficacy and safety of daprodustat compared with darbepoetin alfa in Japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial","volume":"15","author":"Akizawa","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0215","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0220","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ejhf.2132","article-title":"Effect of dapagliflozin on anaemia in DAPA-HF","volume":"23","author":"Docherty","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2025.09.011_bb0230","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ejhf.2409","article-title":"Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-reduced","volume":"24","author":"Ferreira","year":"2022","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:13:18Z","timestamp":1764828798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0914508725002412"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.09.011","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daprodustat for patients with heart failure and renal anemia: A pilot multicenter, open-label, randomized controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}